100 U.S. Patients Treated in Clinical Trial of Baguera C Spinal Disc

By Julie A. Vetalice

100 U.S. Patients Treated in Clinical Trial of Baguera C Spinal Disc

Spineart USA achieved the milestone of 100 patients treated in the single-level U.S. Investigational Device Exemption (IDE) clinical trial of the BAGUERA® C cervical disc. BAGUERA C is an investigational device in the U.S. and is designed to reconstruct the cervical disc following discectomy for symptomatic cervical disc disease.

Spineart is currently conducting, in parallel, a single-level and two-level IDE clinical trial of BAGUERA C at more than 20 sites in the U.S. The two-level study is also expected to hit the 100-patient benchmark in the coming month, bringing the total surgeries performed to more than 200.

BAGUERA C is designed to maintain the natural behavior of a functional spinal unit. This design enables the BAGUERA C nucleus to move in all six degrees of freedom, with independent angular rotations (flexion-extension, lateral bending and axial rotation) along with independent translational motions (anterior-posterior and lateral translations).

Source: Spineart

Product Labels: Cervical Spine, Spine Artificial Disc

Tags: Trial/Study